Can a TENS Unit Help With Tennis Elbow?

The largest and most rigorous trial to date found that adding a TENS unit to standard care for tennis elbow produced no meaningful benefit over standard care alone. At six weeks, the group using TENS actually trailed the control group by a fraction of a point on a ten-point pain scale, and at twelve months neither pain scores nor function showed a statistically significant difference between groups. That result, published in the BMJ, surprised researchers who had designed the trial expecting TENS to outperform usual care by a clinically meaningful margin. The picture is more nuanced than a flat “no,” though, because how TENS works, how tolerance develops, and what tennis elbow actually is all shape whether the device could still play a limited role for some people.

What the Best Trial Actually Found

The TATE trial enrolled 240 adults with tennis elbow from GP practices across Staffordshire, UK. Half received standard primary care management (a GP consultation, medication, advice, and education), while the other half received the same care plus a TENS unit to use at home over six weeks. Researchers had powered the study to detect a 20% difference in pain scores, expecting the TENS group to see a 45% reduction versus a 25% reduction in the control group. That gap never materialized. At six weeks, the adjusted difference in pain improvement was just −0.33 points on a 0–10 scale, favoring the group that did not use TENS. Both groups showed large improvements in pain and function, especially during the first six weeks, but TENS added nothing on top of that natural recovery curve.¹

A later systematic review and meta-analysis reinforced that finding. When TENS was compared against no active treatment for lateral epicondylitis, function scores (measured by the Patient-Rated Tennis Elbow Evaluation) improved by fewer than three points at twelve months, a change that was not statistically significant. Pain scores at twelve months likewise showed no difference.²

Before the TATE trial, only two small studies had tested TENS specifically for tennis elbow. One involved just 12 people per group and ran for only five days; the other used 20 per group and applied a non-standard form of TENS. Both reported some pain reduction, but the sample sizes were too small to draw reliable conclusions.³

How TENS Is Supposed to Work

TENS sends mild electrical pulses through the skin via adhesive electrodes. The leading explanation for why this reduces pain draws on the gate control idea: stimulating large-diameter nerve fibers with electrical impulses can effectively close the “gate” to pain signals traveling along smaller fibers, so fewer pain messages reach the brain.⁴ Beyond that peripheral mechanism, there is evidence that TENS also activates descending pain-inhibitory pathways in the central nervous system, reducing the heightened pain sensitivity (hyperalgesia) that can develop with chronic conditions. Reviews of TENS across many pain conditions have found that both high-frequency and low-frequency settings can produce pain relief when the intensity is set to a strong but comfortable level.⁵

These mechanisms are real and have been demonstrated in laboratory and clinical settings for various types of pain. The question for tennis elbow is not whether TENS can modulate pain signaling at all, but whether that modulation adds anything useful on top of the natural healing trajectory and routine care that tennis elbow tends to follow. For most people, the answer from the TATE trial and subsequent review appears to be no.

Pain Relief Is Not the Same as Healing

Tennis elbow involves degenerative changes in the tendons that attach to the outside of the elbow. It is not primarily an inflammatory condition in the way a fresh sprain is; the tissue undergoes disorganized collagen turnover, microtearing, and failed repair. TENS, by design, targets pain signaling rather than the structural integrity of the tendon. Even if it temporarily dials down the sensation of pain, that does not accelerate the tendon’s healing process.

An animal study on Achilles tendon healing raises a more pointed concern. Researchers applied burst-mode TENS to rats with partial tendon ruptures and found that TENS actually inhibited the production of collagen types I and III and impaired collagen alignment during recovery.⁶ This was a rat study on a different tendon using burst-mode settings, so it cannot be directly translated to human lateral epicondylitis. Still, it suggests that certain forms of electrical stimulation may interfere with tendon repair rather than help it. At a minimum, it undermines any assumption that TENS is automatically harmless for an injured tendon.

This distinction between pain suppression and structural recovery matters practically. If TENS masks pain while you continue activities that stress the tendon, you could slow your recovery. The logic of treating tennis elbow has generally shifted toward progressive loading exercises that stimulate tendon remodeling under controlled stress, not toward pain-masking strategies that leave the underlying tissue unchanged.

Analgesic Tolerance Develops Fast

Even for people who do notice short-term relief from TENS, there is a built-in limitation: tolerance. In a human study, researchers found that applying either high-frequency or low-frequency TENS at the same dose each day caused the pain-relieving effect to fade by around the fourth or fifth consecutive day. The mechanism mirrors opioid tolerance at the receptor level in the central nervous system, which makes sense given that TENS-mediated pain relief partly involves the body’s own opioid pathways.⁷

An animal study explored whether gradually increasing the stimulation intensity could outrun tolerance. Rats that received the same TENS intensity every day showed tolerance by day five, but rats whose intensity was bumped up by about 10% each day maintained pain relief throughout the study period.⁸ Whether this translates neatly into human practice is uncertain, but the implication is clear: if you keep your TENS unit on the same setting day after day, any pain relief you notice in the first session or two may vanish within a week. Simply cranking it up a little each session might extend the window, though there is an obvious ceiling to how high you can go before the sensation becomes unpleasant.

How TENS Compares to Corticosteroid Injections

Corticosteroid injections are one of the most commonly offered treatments for tennis elbow, and their track record is worth noting for context. Trials have consistently shown that injections produce dramatic short-term pain relief, often within days. But that relief comes with a catch: higher recurrence rates compared to groups that did not receive injections. The injection appears to suppress symptoms without addressing the underlying tendon pathology, and when the steroid effect wears off, the condition often returns in a worse state than if the patient had simply waited it out.³

In that sense, TENS and corticosteroid injections share a family resemblance: both aim to reduce pain rather than fix the tendon. The difference is that corticosteroid injections at least produce robust short-term relief (even if it backfires later), while TENS for tennis elbow has not even demonstrated that. If the question is purely about getting through the next few days with less pain, injections win handily. If the question is about long-term recovery, neither TENS nor injections have shown a meaningful advantage over simply doing structured rehabilitation exercises and waiting for the tendon to heal on its own.

The Economics of Adding TENS to Standard Care

The TATE trial also ran a formal economic evaluation. Adding TENS to standard primary care cost an extra £33 in direct healthcare costs and £65 in broader societal costs per patient. These are modest sums, but they bought essentially no additional benefit. The mean difference in pain improvement was just 0.11 points, and quality-of-life measures showed negligible differences in either direction. The cost-effectiveness analysis generated a wide confidence interval that crossed zero in every direction, meaning you could not even say with reasonable confidence whether TENS saved or wasted money.⁹

For someone who already owns a TENS unit from treating a different condition, the marginal cost of trying it on tennis elbow is close to zero. But for someone considering buying a device specifically for this purpose, the evidence does not support the investment. Consumer TENS units typically cost between $25 and $100, and the electrodes need regular replacement. That is not a lot of money, but it is money spent on something that the best available evidence says does not work for this particular condition.

Intensity and Electrode Placement If You Still Want to Try

If you already have a TENS unit and want to experiment, a few practical details from the research are worth knowing. The TATE trial used high-frequency settings: 110 Hz with a pulse duration of 200 microseconds, at an intensity described as “strong but tolerable.”³ That intensity guidance turns up across TENS research more broadly. A study testing a proper placebo device found that only participants using active TENS at higher amplitudes (at or above 17 milliamps) showed meaningful increases in pain thresholds, while those using lower amplitudes did not.¹⁰ In other words, if the stimulation feels like a barely perceptible tingle, it is probably too low to do anything.

Where you place the electrodes may matter less than you think. An experimental pain study found that the pain-relieving effect of TENS was similar whether electrodes were placed directly at the painful site, over the related nerve trunk, or at a distant segmental location. The researchers concluded that clinicians could choose the most convenient placement based on the patient’s clinical situation without sacrificing effectiveness.¹¹ For tennis elbow, most people place electrodes around the lateral epicondyle and the forearm extensor muscles, but this finding suggests that alternative placements could work if direct application is uncomfortable or impractical.

Why Placebo Effects Complicate the Picture

TENS research has a persistent blinding problem. In the study that tested a new sham device, investigators were correctly blinded 100% of the time with the sham, but only 7% of the time with active TENS. Subjects were blinded 40% of the time with the sham and just 13% with active TENS.¹⁰ The reason is obvious: active TENS produces a noticeable tingling or buzzing sensation. Participants generally know whether they are receiving real stimulation, and that knowledge can trigger a placebo response.

The TATE trial sidestepped this by not using a sham device at all. It compared TENS plus usual care against usual care alone, which means any placebo benefit from the TENS device would have shown up as a group difference. The fact that no difference appeared suggests that even the combination of real electrical stimulation plus placebo expectation was not enough to outperform simple GP management for tennis elbow. This is actually a stronger indictment than a sham-controlled trial that shows TENS outperforms sham, because it says the whole package of using the device, including any psychological boost, still does not beat doing nothing extra.

Blood Flow and the Vascular Angle

One proposed secondary benefit of TENS is increased local blood flow, which could theoretically support tissue healing. A study in healthy volunteers did find that TENS produced a dose-dependent increase in forearm blood flow, with high-dose stimulation reducing forearm vascular resistance by about 17% compared to the unstimulated arm.¹² That sounds encouraging until you note two caveats. First, the effect was measured in healthy people; it did not appear in patients with vascular disease, suggesting it depends on normal vascular function. Second, even in healthy subjects, the vasodilation was transient, linked to the period of stimulation itself. There is no evidence connecting this brief circulatory bump to meaningful tendon repair. Blood flow is necessary for healing, but tennis elbow is not typically a condition where blood supply is the rate-limiting factor. The tendon’s problem is disordered collagen remodeling, not ischemia.

When TENS Might Still Make Sense

Despite the underwhelming evidence for tennis elbow specifically, there are narrow scenarios where trying TENS is not unreasonable. If you have a flare-up that is severe enough to disrupt sleep or prevent you from doing the rehabilitation exercises that actually promote tendon healing, a few sessions of TENS to take the edge off pain could be practical. The goal in that case is not treating the tennis elbow with TENS but using temporary pain modulation to stay on track with your rehab program. Think of it like taking an over-the-counter painkiller before a physiotherapy session: the pill is not curing anything, but it lets you do the work that matters.

Keep in mind the tolerance issue discussed earlier. If you plan to use TENS in this supportive role, using it intermittently rather than every day, or gradually increasing intensity across sessions, may preserve whatever analgesic effect it provides. The evidence for these strategies is still largely from animal models and a single human trial, so treat them as reasonable guesses rather than proven protocols. Standard contraindications for TENS apply regardless of the condition being treated: avoid placing electrodes over the front of the neck, over the eyes, on broken skin, or over implanted electrical devices like pacemakers. Pregnant individuals are typically advised to avoid TENS on the abdomen and lower back.

Tennis elbow resolves on its own in the majority of cases within six to twelve months, even without treatment. The recovery curve in the TATE trial illustrates this neatly: both the TENS group and the usual-care group improved substantially over time, with the steepest gains in the first six weeks. The most evidence-backed accelerators of that natural process are eccentric and isometric loading exercises for the wrist extensors, not electrical gadgets. A TENS unit is unlikely to hurt you, but spending the same time and attention on a structured exercise program will almost certainly get you further.